166 related articles for article (PubMed ID: 31390175)
1. Surface-Modified G4 PAMAM Dendrimers Cross the Blood-Brain Barrier Following Multiple Tail-Vein Injections in C57BL/6J Mice.
Srinageshwar B; Dils A; Sturgis J; Wedster A; Kathirvelu B; Baiyasi S; Swanson D; Sharma A; Dunbar GL; Rossignol J
ACS Chem Neurosci; 2019 Sep; 10(9):4145-4150. PubMed ID: 31390175
[TBL] [Abstract][Full Text] [Related]
2. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice.
Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421
[TBL] [Abstract][Full Text] [Related]
3. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration.
Lesniak WG; Chu C; Jablonska A; Behnam Azad B; Zwaenepoel O; Zawadzki M; Lisok A; Pomper MG; Walczak P; Gettemans J; Janowski M
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1940-1951. PubMed ID: 31161257
[TBL] [Abstract][Full Text] [Related]
5. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.
Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL
Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
7.
Wei X; Liu Z; Zhao Z
Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
[TBL] [Abstract][Full Text] [Related]
8. Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats.
Karolczak K; Rozalska S; Wieczorek M; Labieniec-Watala M; Watala C
Int J Pharm; 2012 Oct; 436(1-2):508-18. PubMed ID: 22721855
[TBL] [Abstract][Full Text] [Related]
9. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
Albertazzi L; Gherardini L; Brondi M; Sulis Sato S; Bifone A; Pizzorusso T; Ratto GM; Bardi G
Mol Pharm; 2013 Jan; 10(1):249-60. PubMed ID: 23163881
[TBL] [Abstract][Full Text] [Related]
10. Complexes of dendrimers with bovine serum albumin.
Mandeville JS; Tajmir-Riahi HA
Biomacromolecules; 2010 Feb; 11(2):465-72. PubMed ID: 20085247
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of PAMAM Dendrimers Internalization in Hippocampal Neurons.
Vidal F; Vásquez P; Díaz C; Nova D; Alderete J; Guzmán L
Mol Pharm; 2016 Oct; 13(10):3395-3403. PubMed ID: 27556289
[TBL] [Abstract][Full Text] [Related]
12. Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia.
Bertero A; Boni A; Gemmi M; Gagliardi M; Bifone A; Bardi G
Nanotoxicology; 2014 Mar; 8(2):158-68. PubMed ID: 23298388
[TBL] [Abstract][Full Text] [Related]
13. Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme.
Sahoo RK; Gupta T; Batheja S; Goyal AK; Gupta U
Curr Drug Metab; 2022; 23(9):708-722. PubMed ID: 35713127
[TBL] [Abstract][Full Text] [Related]
14. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.
Fana M; Gallien J; Srinageshwar B; Dunbar GL; Rossignol J
Int J Nanomedicine; 2020; 15():2789-2808. PubMed ID: 32368055
[TBL] [Abstract][Full Text] [Related]
15. Probing the binding of cationic lipids with dendrimers.
Mandeville JS; Bourassa P; Tajmir-Riahi HA
Biomacromolecules; 2013 Jan; 14(1):142-52. PubMed ID: 23130659
[TBL] [Abstract][Full Text] [Related]
16. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
[TBL] [Abstract][Full Text] [Related]
17. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
[TBL] [Abstract][Full Text] [Related]
18. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
19. Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.
Alnasser Y; Kambhampati SP; Nance E; Rajbhandari L; Shrestha S; Venkatesan A; Kannan RM; Kannan S
Molecules; 2018 Apr; 23(5):. PubMed ID: 29702566
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs.
Mignani S; Shi X; Karpus A; Majoral JP
Eur J Med Chem; 2021 Jan; 209():112905. PubMed ID: 33069435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
